Search Results

Takeda announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval, under exceptional circumstances, of recombinant ADAMTS13 for the treatment of ADAMTS13 deficiency in children and adult patients with cTTP.

Ocular Therapeutix, Inc. will host an Investor Day on Thursday, June 13, 2024.

Zynex, Inc. announced that it will participate in an analyst-led fireside chat on an RBC Capital Markets 2024 Medical Device Strategy & Innovation Call at 11:00 AM ET on Thursday, June 13, 2024.

Carisma Therapeutics Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, announced that the Company’s virtual annual meeting of stockholders held on June 13, 2024 was convened and adjourned, without any business being conducted, due to technical difficulties with the third-party hosting site.

UroGen Pharma Ltd. today shared additional details about the upcoming ENVISION virtual data event on Thursday, June 13, 2024, at 11:00 a.m. Eastern Time.

Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on June 13, 2024, at 4:15 p.m. ET.

Intelligent Bio Solutions Inc. today announced that its management team will participate in the Sidoti Small-Cap Conference being held virtually June 12-13, 2024.

According to latest report, the U.S. Single-use Bioprocessing market size was USD 8.15 billion in 2023, calculated at USD 9.43 billion in 2024, and is expected to reach around USD 35.13 billion by 2033, expanding at a CAGR of 15.73% from 2024 to 2033.

Senstar Technologies Corporation (NASDAQ: SNT), a leading international provider of comprehensive physical, video and access control security products and solutions, will report financial results for its first quarter ended March 31, 2024, on Thursday, June 13, 2024.

NEXGEL, Inc. today announced it will report its financial results for the first quarter 2024, after the market closes on May 13, 2024.